HEADER HYDROLASE/VIRAL PROTEIN 28-SEP-22 8H06 TITLE CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON BA.4/5 RBD IN COMPLEX WITH TITLE 2 HUMAN ACE2 (LOCAL REFINEMENT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROCESSED ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: SPIKE PROTEIN S1; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: RBD; COMPND 9 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2, UNQ868/PRO1885; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_TAXID: 2697049; SOURCE 12 GENE: S, 2; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, OMICRON BA.4/5, SPIKE PROTEIN, VIRAL PROTEIN, HYDROLASE- KEYWDS 2 VIRAL PROTEIN COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR Z.N.ZHAO,Y.F.XIE,J.X.QI,G.F.GAO REVDAT 2 02-AUG-23 8H06 1 JRNL REVDAT 1 19-JUL-23 8H06 0 JRNL AUTH Z.ZHAO,Y.XIE,B.BAI,C.LUO,J.ZHOU,W.LI,Y.MENG,L.LI,D.LI,X.LI, JRNL AUTH 2 X.LI,X.WANG,J.SUN,Z.XU,Y.SUN,W.ZHANG,Z.FAN,X.ZHAO,L.WU,J.MA, JRNL AUTH 3 O.Y.LI,G.SHANG,Y.CHAI,K.LIU,P.WANG,G.F.GAO,J.QI JRNL TITL STRUCTURAL BASIS FOR RECEPTOR BINDING AND BROADER JRNL TITL 2 INTERSPECIES RECEPTOR RECOGNITION OF CURRENTLY CIRCULATING JRNL TITL 3 OMICRON SUB-VARIANTS. JRNL REF NAT COMMUN V. 14 4405 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37479708 JRNL DOI 10.1038/S41467-023-39942-Z REMARK 2 REMARK 2 RESOLUTION. 2.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.660 REMARK 3 NUMBER OF PARTICLES : 355600 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8H06 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1300032541. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYO-EM STRUCTURE OF SARS-COV-2 REMARK 245 OMICRON BA.4/5 RBD IN COMPLEX REMARK 245 WITH HUMAN ACE2 (LOCAL REMARK 245 REFINEMENT); ANGIOTENSIN- REMARK 245 CONVERTING ENZYME 2; OMICRON REMARK 245 BA.4/5 RBD REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 33 -8.85 -57.12 REMARK 500 ASN A 137 87.47 -159.56 REMARK 500 ASN A 277 1.12 -66.58 REMARK 500 ASN A 322 -169.28 -79.30 REMARK 500 ASN A 599 31.27 -93.96 REMARK 500 SER B 408 -5.11 -59.92 REMARK 500 PHE B 497 123.74 -11.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 705 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 374 NE2 REMARK 620 2 HIS A 378 NE2 88.9 REMARK 620 3 GLU A 402 OE2 110.2 96.7 REMARK 620 N 1 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-34409 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON BA.4/5 RBD IN COMPLEX WITH REMARK 900 HUMAN ACE2 (LOCAL REFINEMENT) DBREF 8H06 A 19 614 UNP Q9BYF1 ACE2_HUMAN 19 614 DBREF 8H06 B 333 527 UNP P0DTC2 SPIKE_SARS2 333 527 SEQADV 8H06 ASP B 339 UNP P0DTC2 GLY 339 VARIANT SEQADV 8H06 PHE B 371 UNP P0DTC2 SER 371 VARIANT SEQADV 8H06 PRO B 373 UNP P0DTC2 SER 373 VARIANT SEQADV 8H06 PHE B 375 UNP P0DTC2 SER 375 VARIANT SEQADV 8H06 ALA B 376 UNP P0DTC2 THR 376 VARIANT SEQADV 8H06 ASN B 405 UNP P0DTC2 ASP 405 VARIANT SEQADV 8H06 SER B 408 UNP P0DTC2 ARG 408 VARIANT SEQADV 8H06 ASN B 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 8H06 LYS B 440 UNP P0DTC2 ASN 440 VARIANT SEQADV 8H06 ARG B 452 UNP P0DTC2 LEU 452 VARIANT SEQADV 8H06 ASN B 477 UNP P0DTC2 SER 477 VARIANT SEQADV 8H06 LYS B 478 UNP P0DTC2 THR 478 VARIANT SEQADV 8H06 ALA B 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 8H06 VAL B 486 UNP P0DTC2 PHE 486 VARIANT SEQADV 8H06 ARG B 498 UNP P0DTC2 GLN 498 VARIANT SEQADV 8H06 TYR B 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 8H06 HIS B 505 UNP P0DTC2 TYR 505 VARIANT SEQRES 1 A 596 SER THR ILE GLU GLU GLN ALA LYS THR PHE LEU ASP LYS SEQRES 2 A 596 PHE ASN HIS GLU ALA GLU ASP LEU PHE TYR GLN SER SER SEQRES 3 A 596 LEU ALA SER TRP ASN TYR ASN THR ASN ILE THR GLU GLU SEQRES 4 A 596 ASN VAL GLN ASN MET ASN ASN ALA GLY ASP LYS TRP SER SEQRES 5 A 596 ALA PHE LEU LYS GLU GLN SER THR LEU ALA GLN MET TYR SEQRES 6 A 596 PRO LEU GLN GLU ILE GLN ASN LEU THR VAL LYS LEU GLN SEQRES 7 A 596 LEU GLN ALA LEU GLN GLN ASN GLY SER SER VAL LEU SER SEQRES 8 A 596 GLU ASP LYS SER LYS ARG LEU ASN THR ILE LEU ASN THR SEQRES 9 A 596 MET SER THR ILE TYR SER THR GLY LYS VAL CYS ASN PRO SEQRES 10 A 596 ASP ASN PRO GLN GLU CYS LEU LEU LEU GLU PRO GLY LEU SEQRES 11 A 596 ASN GLU ILE MET ALA ASN SER LEU ASP TYR ASN GLU ARG SEQRES 12 A 596 LEU TRP ALA TRP GLU SER TRP ARG SER GLU VAL GLY LYS SEQRES 13 A 596 GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL LEU LYS SEQRES 14 A 596 ASN GLU MET ALA ARG ALA ASN HIS TYR GLU ASP TYR GLY SEQRES 15 A 596 ASP TYR TRP ARG GLY ASP TYR GLU VAL ASN GLY VAL ASP SEQRES 16 A 596 GLY TYR ASP TYR SER ARG GLY GLN LEU ILE GLU ASP VAL SEQRES 17 A 596 GLU HIS THR PHE GLU GLU ILE LYS PRO LEU TYR GLU HIS SEQRES 18 A 596 LEU HIS ALA TYR VAL ARG ALA LYS LEU MET ASN ALA TYR SEQRES 19 A 596 PRO SER TYR ILE SER PRO ILE GLY CYS LEU PRO ALA HIS SEQRES 20 A 596 LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR ASN LEU SEQRES 21 A 596 TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO ASN ILE SEQRES 22 A 596 ASP VAL THR ASP ALA MET VAL ASP GLN ALA TRP ASP ALA SEQRES 23 A 596 GLN ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE VAL SER SEQRES 24 A 596 VAL GLY LEU PRO ASN MET THR GLN GLY PHE TRP GLU ASN SEQRES 25 A 596 SER MET LEU THR ASP PRO GLY ASN VAL GLN LYS ALA VAL SEQRES 26 A 596 CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY ASP PHE SEQRES 27 A 596 ARG ILE LEU MET CYS THR LYS VAL THR MET ASP ASP PHE SEQRES 28 A 596 LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN TYR ASP SEQRES 29 A 596 MET ALA TYR ALA ALA GLN PRO PHE LEU LEU ARG ASN GLY SEQRES 30 A 596 ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU ILE MET SEQRES 31 A 596 SER LEU SER ALA ALA THR PRO LYS HIS LEU LYS SER ILE SEQRES 32 A 596 GLY LEU LEU SER PRO ASP PHE GLN GLU ASP ASN GLU THR SEQRES 33 A 596 GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR ILE VAL SEQRES 34 A 596 GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS TRP ARG SEQRES 35 A 596 TRP MET VAL PHE LYS GLY GLU ILE PRO LYS ASP GLN TRP SEQRES 36 A 596 MET LYS LYS TRP TRP GLU MET LYS ARG GLU ILE VAL GLY SEQRES 37 A 596 VAL VAL GLU PRO VAL PRO HIS ASP GLU THR TYR CYS ASP SEQRES 38 A 596 PRO ALA SER LEU PHE HIS VAL SER ASN ASP TYR SER PHE SEQRES 39 A 596 ILE ARG TYR TYR THR ARG THR LEU TYR GLN PHE GLN PHE SEQRES 40 A 596 GLN GLU ALA LEU CYS GLN ALA ALA LYS HIS GLU GLY PRO SEQRES 41 A 596 LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU ALA GLY SEQRES 42 A 596 GLN LYS LEU PHE ASN MET LEU ARG LEU GLY LYS SER GLU SEQRES 43 A 596 PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY ALA LYS SEQRES 44 A 596 ASN MET ASN VAL ARG PRO LEU LEU ASN TYR PHE GLU PRO SEQRES 45 A 596 LEU PHE THR TRP LEU LYS ASP GLN ASN LYS ASN SER PHE SEQRES 46 A 596 VAL GLY TRP SER THR ASP TRP SER PRO TYR ALA SEQRES 1 B 195 THR ASN LEU CYS PRO PHE ASP GLU VAL PHE ASN ALA THR SEQRES 2 B 195 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 B 195 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN PHE SEQRES 4 B 195 ALA PRO PHE PHE ALA PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 B 195 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 B 195 ASP SER PHE VAL ILE ARG GLY ASN GLU VAL SER GLN ILE SEQRES 7 B 195 ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN TYR SEQRES 8 B 195 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 B 195 ASN SER ASN LYS LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 B 195 ASN TYR ARG TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 B 195 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 B 195 GLY ASN LYS PRO CYS ASN GLY VAL ALA GLY VAL ASN CYS SEQRES 13 B 195 TYR PHE PRO LEU GLN SER TYR GLY PHE ARG PRO THR TYR SEQRES 14 B 195 GLY VAL GLY HIS GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 B 195 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET FUC D 3 10 HET NAG A 701 14 HET NAG A 702 14 HET NAG A 703 14 HET NAG A 704 14 HET ZN A 705 1 HET NAG B 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 NAG 9(C8 H15 N O6) FORMUL 4 FUC C6 H12 O5 FORMUL 9 ZN ZN 2+ HELIX 1 AA1 THR A 20 ASN A 53 1 34 HELIX 2 AA2 THR A 55 ALA A 80 1 26 HELIX 3 AA3 GLN A 81 TYR A 83 5 3 HELIX 4 AA4 THR A 92 GLN A 101 1 10 HELIX 5 AA5 ASN A 103 LEU A 108 5 6 HELIX 6 AA6 SER A 109 THR A 129 1 21 HELIX 7 AA7 GLY A 147 SER A 155 1 9 HELIX 8 AA8 TYR A 158 VAL A 172 1 15 HELIX 9 AA9 GLY A 173 GLN A 175 5 3 HELIX 10 AB1 LEU A 176 ASN A 194 1 19 HELIX 11 AB2 ASP A 198 GLY A 205 1 8 HELIX 12 AB3 ASP A 206 GLU A 208 5 3 HELIX 13 AB4 GLY A 220 MET A 249 1 30 HELIX 14 AB5 TRP A 275 ASN A 277 5 3 HELIX 15 AB6 LEU A 278 VAL A 283 1 6 HELIX 16 AB7 VAL A 293 GLN A 300 1 8 HELIX 17 AB8 ASP A 303 SER A 317 1 15 HELIX 18 AB9 GLY A 326 SER A 331 1 6 HELIX 19 AC1 THR A 365 TYR A 385 1 21 HELIX 20 AC2 PRO A 389 ARG A 393 5 5 HELIX 21 AC3 GLY A 399 ALA A 412 1 14 HELIX 22 AC4 THR A 414 ILE A 421 1 8 HELIX 23 AC5 GLU A 433 VAL A 447 1 15 HELIX 24 AC6 THR A 449 GLY A 466 1 18 HELIX 25 AC7 PRO A 469 ASP A 471 5 3 HELIX 26 AC8 GLN A 472 LYS A 481 1 10 HELIX 27 AC9 ASP A 499 SER A 502 5 4 HELIX 28 AD1 LEU A 503 ASN A 508 1 6 HELIX 29 AD2 ILE A 513 ALA A 533 1 21 HELIX 30 AD3 PRO A 538 CYS A 542 5 5 HELIX 31 AD4 THR A 548 ARG A 559 1 12 HELIX 32 AD5 PRO A 565 GLY A 575 1 11 HELIX 33 AD6 VAL A 581 PHE A 588 1 8 HELIX 34 AD7 PHE A 588 ASN A 599 1 12 HELIX 35 AD8 LYS A 600 SER A 602 5 3 HELIX 36 AD9 PHE B 338 ASN B 343 1 6 HELIX 37 AE1 SER B 366 ASN B 370 5 5 HELIX 38 AE2 ASN B 405 ILE B 410 5 6 HELIX 39 AE3 GLY B 416 ASN B 422 1 7 HELIX 40 AE4 SER B 438 SER B 443 1 6 HELIX 41 AE5 GLY B 502 HIS B 505 5 4 SHEET 1 AA1 2 LYS A 131 CYS A 133 0 SHEET 2 AA1 2 CYS A 141 LEU A 143 -1 O LEU A 142 N VAL A 132 SHEET 1 AA2 2 LEU A 262 PRO A 263 0 SHEET 2 AA2 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA3 2 THR A 347 ASP A 350 0 SHEET 2 AA3 2 PHE A 356 LEU A 359 -1 O ARG A 357 N TRP A 349 SHEET 1 AA4 5 ASN B 354 ILE B 358 0 SHEET 2 AA4 5 ASN B 394 ARG B 403 -1 O ALA B 397 N LYS B 356 SHEET 3 AA4 5 PRO B 507 GLU B 516 -1 O VAL B 510 N PHE B 400 SHEET 4 AA4 5 GLY B 431 ASN B 437 -1 N TRP B 436 O ARG B 509 SHEET 5 AA4 5 ALA B 376 TYR B 380 -1 N TYR B 380 O GLY B 431 SHEET 1 AA5 2 ARG B 452 ARG B 454 0 SHEET 2 AA5 2 LEU B 492 SER B 494 -1 O GLN B 493 N TYR B 453 SHEET 1 AA6 2 TYR B 473 GLN B 474 0 SHEET 2 AA6 2 CYS B 488 TYR B 489 -1 O TYR B 489 N TYR B 473 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.03 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.03 SSBOND 4 CYS B 336 CYS B 361 1555 1555 2.03 SSBOND 5 CYS B 379 CYS B 432 1555 1555 2.06 SSBOND 6 CYS B 391 CYS B 525 1555 1555 2.04 SSBOND 7 CYS B 480 CYS B 488 1555 1555 2.03 LINK ND2 ASN A 53 C1 NAG A 701 1555 1555 1.45 LINK ND2 ASN A 90 C1 NAG A 702 1555 1555 1.44 LINK ND2 ASN A 103 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN A 322 C1 NAG A 703 1555 1555 1.44 LINK ND2 ASN A 432 C1 NAG A 704 1555 1555 1.44 LINK ND2 ASN A 546 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN B 343 C1 NAG B 601 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.45 LINK O6 NAG D 1 C1 FUC D 3 1555 1555 1.44 LINK NE2 HIS A 374 ZN ZN A 705 1555 1555 2.10 LINK NE2 HIS A 378 ZN ZN A 705 1555 1555 2.10 LINK OE2 GLU A 402 ZN ZN A 705 1555 1555 2.01 CISPEP 1 GLU A 145 PRO A 146 0 -4.08 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000